Gene therapy has the potential to dramatically benefit patients with genetic blood disorders, but a small study on participants in a clinical trial for sickle cell disease suggests that a key process ...
Now, following up on that success, a large Chinese collaboration has followed up with a description of an improved gene ...
Alternative splicing is a genetic process where different segments of genes are removed, and the remaining pieces are joined together during transcription to messenger RNA (mRNA). This mechanism ...
With the FDA expecting to approve 10–20 Cell and Gene Therapies (CGTs) annually by 2025, it is evident that the field will continue to hold immense commercial and medical opportunities. To harness ...
NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to ...
In heart failure, the heart can no longer supply the body with enough blood. The condition often develops over many years, ...
A Stanford University biochemist who has greatly advanced human understanding of how cells copy themselves, and what controls the process, will receive the 2001 Welch Award tonight. Roger Kornberg, 54 ...
Alternative splicing is a genetic process where different segments of genes are removed, and the remaining pieces are joined together during transcription to messenger RNA (mRNA). This mechanism ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results